It has recently been shown that the lactation-induced inflammatory state in the liver of dairy cows is accompanied by activation of the nuclear factor E2-related factor 2 (Nrf2) pathway, which regulates the expression of antioxidant and cytoprotective genes and thereby protects tissues from inflammatory mediators and reactive oxygen species (ROS). The present study aimed to study whether the Nrf2 pathway is activated also in the liver of lactating sows.
Findings
Transcript levels of known Nrf2 target genes, UGT1A1 (encoding glucuronosyltransferase 1 family, polypeptide A1), HO-1 (encoding heme oxygenase 1), NQO1 (encoding NAD(P)H dehydrogenase, quinone 1), GPX1 (encoding glutathione peroxidase), PRDX6 (encoding peroxiredoxin 6), TXNRD1 (encoding thioredoxin reductase 1), and SOD (encoding superoxide dismutase), in the liver are significantly elevated (between 1.7 and 3.1 fold) in lactating sows compared to non-lactating sows. The inflammatory state in the liver was evidenced by the finding that transcript levels of genes encoding acute phase proteins, namely haptoglobin (HP), fibrinogen γ (FGG), complement factor B (CFB), C-reactive protein (CRP) and lipopolysaccharide-binding protein (LBP), were significantly higher (2 to 8.7 fold) in lactating compared to non-lactating sows.
Conclusions
The results of the present study indicate that the Nrf2 pathway in the liver of sows is activated during lactation. The activation of Nrf2 pathway during lactation in sows might be interpreted as a physiologic means to counteract the inflammatory process and to protect the liver against damage induced by inflammatory signals and ROS.
Typical characteristics for the lactation phase are dramatic increases in the energy and nutrient requirement of the organism, which are usually met by an elevation of food intake and a mobilisation of body’s energy stores [1, 2]. In dairy cows, lactation was also shown to induce immune and inflammatory responses in the liver [3, 4]. In contrast to extensive research in rodents and cows on the mechanisms underlying the lactation-induced metabolic and immunologic adaptations [3–6], only limited information is available in sows in this regard [7, 8]. In an attempt to improve the knowledge about metabolic and immunologic adaptations during lactation in sows we have recently analyzed the changes in the hepatic transcriptome of sows during lactation on a genome-wide level [9]. Besides the expected induction of energy-generating pathways in the liver during lactation, we found that lactation causes an induction of an inflammatory state as evidenced from the marked induction of several acute phase proteins in the liver of lactating sows [9]. Acute phase proteins are secreted from hepatocytes in response to inflammatory stimuli and are therefore established markers of inflammation in both human and veterinary clinical pathologies, which indicates that lactation induces an inflammatory state in the liver of sows, like in dairy cows [3, 4]. Interestingly, we have recently reported that the inflammatory state in the liver of dairy cows during lactation is accompanied by activation of the nuclear factor E2-related factor 2 (Nrf2) stress signalling pathway (unpublished observations). Nrf2 is a redox-sensitive transcription factor which upon activation by inflammatory stimuli but also reactive oxygen species (ROS), xenobiotics or electrophiles [10] induces the transcription of a large set of genes encoding various antioxidative proteins such as glutathione peroxidase 1 (encoded by GPX1), superoxide dismutase (encoded by SOD) and cytoprotective proteins [heme oxygenase 1 (encoded by HO-1), NAD(P)H dehydrogenase, quinone 1 (encoded by NQO1), peroxiredoxin 6 (encoded by PRDX6), thioredoxin reductase 1 (encoded by TXNRD1), glucuronosyltransferase 1 family, polypeptide A1 (encoded by UGT1A1)] and thereby protects tissues from inflammatory damage and neutralizes ROS produced under pro-inflammatory conditions [11]. In light of the observation that the lactation-induced inflammatory state in the liver of dairy cows is accompanied by activation of the Nrf2 pathway and in order to further improve knowledge about the mechanisms underlying the lactation-induced adaptations during lactation in sows, the present study aimed to investigate whether the Nrf2 pathway is activated in the liver of lactating sows.
The animal study was carried out in accordance with established guidelines for the care and handling of laboratory animals and was approved by the local Animal Welfare Authorities (Regierungspräsidium Giessen; permission no: GI 19/3-No. 29/2010). As described recently in more detail [9], the experiment was performed with twenty second parity sows (Large White & German Landrace), which were artificially inseminated with semen from boars of the own breed, and kept in single crates until day 21 of pregnancy. From day 21 to 110 of pregnancy, the sows were kept in groups in pens that had fully slatted floors, nipple drinkers and feeding stations. On day 110 of pregnancy, they were moved to the farrowing accommodation where they were housed in single farrowing pens. Throughout pregnancy, sows of both groups were fed a commercial diet for gestating sows ad libitum. After farrowing, the sows were randomly assigned into two groups of 10 animals each. In the first group of sows, all piglets were removed from the sow (“non-lactating group”) 24 h after parturition. This group served as the non-lactating control. In the second group, litters were standardised to 12 piglets per sow (“lactating group”). Throughout lactation until the end of the experiment the sows received a diet for lactating sows. Until day 6 after farrowing, the amount of feed given to the lactating sows was successively increased, and from day 7 after farrowing and thereafter the sows were fed individual amounts of feed depending on their body weights. In the non-lactating group, each sow received an amount of food sufficient to cover the individual energy and nutrient requirement for maintenance. On day 20 after farrowing, liver tissue was taken by biopsy and blood was collected from Vena jugularis. A full description of the housing condition, diet composition, feeding regime and sample collection including biopsy sample procedure can be found in our recent publication [9]. RNA isolation from frozen liver biopsies and quantitative real-time PCR (qPCR) analysis were performed as described recently in detail by Keller et al.[12]. Characteristics of primers and primer performance data used for qPCR analysis are shown in Table 1. Plasma levels of TBARS were measured in plasma using a modified version of the TBARS assay [13]. Statistical analysis was performed by one way analysis of variance. Fisher’s multiple range test was used to generate significant F-values of differences with P < 0.05.
Table 1
Characteristics of primers and primer performance data used for qPCR
Gene symbol
Forward primer (from 5’ to 3’)
Product size (bp)
NCBI GenBank
Slope
R2#
Efficiency*
M
Reverse primer (from 5’ to 3’)
Reference genes
RSP9
GTCGCAAGACTTATGTGACC
325
XM_003356050
-0.28
0.999
1.91
0.053
AGCTTAAAGACCTGGGTCT
ATP5G1
CAGTCACCTTGAGCCGGGCA
94
NM_001025218
-0.30
0.998
1.99
0.054
TAGCGCCCCGGTGGTTTGC
GSR
AGCGCGATGCCTACGTGAGC
175
AY368271
-0.29
0.997
1.94
0.055
GGTACGCCGCCTGTGGCAAT
ACTB
GACATCCGCAAGGACCTCTA
205
XM_003124280
-0.32
0.992
2.1
0.064
ACATCTGCTGGAAGGTGGAC
SHAS2
GAAAAGGCTAACCTACCCTG
218
NM_214053
-0.21
0.996
1.65
0.076
TGTTGGACAAGACCAGTTGG
Target genes
HP
ACAGATGACAGCTGCCCAAA
188
NM_214000
-0.30
0.997
1.99
CCGCACACTGCTTCACATTC
FGG
GACATCTGTCTCCTACTGGA
375
NM_001244524
-0.29
0.999
1.95
CATGACACTTGTTCATCCAC
CFB
CTCAACGCAAAGACCGCAAA
106
NM_001101824
-0.29
0.998
1.96
AAATGGGCCTGATGGTCTGG
CRP
CCTTTGTCTTCCCCAAAGAG
563
NM_213844
-0.28
0.999
1.91
CACCTCGCCACTCATTTCAT
LBP
ACCGCTCCCCAGTTGGCTTC
406
NM_001128435
-0.29
0.999
1.96
AGCGCGGCGGACACATTAGT
NQO1
CCAGCAGCCCGGCCAATCTG
160
NM_001159613
-0.28
0.997
1.89
AGGTCCGACACGGCGACCTC
TXNRD1
CTTTACCTTATTGCCCGGGT
162
NM_214154
-0.30
0.999
1.98
GTTCACCGATTTTGTTGGCC
UGT1A1
GATCCTTTCCTGCAACGCAT
313
XM_003483776
-0.28
0.996
1.91
GGAAGGTCATGTGATCTGAG
HO-1
AGCTGTTTCTGAGCCTCCAA
130
NM_001004027
-0.30
0.998
1.98
CAAGACGGAAACACGAGACA
PRDX6
GGCCGCATCCGTTTCCACGA
280
NM_214408
-0.29
0.998
1.95
ACTGGATGGCAAGGTCCCGACT
SOD
TCCATGTCCATCAGTTTGGA
250
NM_001190422
-0.27
0.998
1.88
CTGCCCAAGTCATCTGGTTT
GPX1
GGCACAACGGTGCGGGACTA AGGCGAAGAGCGGGTGAGCA
235
NM_214201
-0.29
0.998
1.96
#Coefficient of determination of the standard curve. *The efficiency is determined by [10-slope].
As expected, evaluation of body weight development of sows throughout lactation revealed that sows of both groups lost body weight but that body weight loss was greater in lactating than in non-lactating sows despite the fact that lactating sows had a markedly greater feed intake [9]. Estimation of the energy balance of the sows revealed that lactating sows are in a strong negative energy balance during lactation indicating that the increased feed intake was not sufficient to fully compensate the body weight loss. In order to evaluate activation of Nrf2 pathway in the liver of sows we determined transcript levels of several known Nrf2 target genes in the liver samples. The results of the present study clearly show that the transcript levels of known Nrf2 target genes, UGT1A1, HO-1, NQO1, GPX1, PRDX6, TXNRD1, and SOD, in the liver are markedly elevated (between 1.7 and 3.1 fold) in lactating sows compared to non-lactating sows (P < 0.05, Table 2). Given that the above mentioned genes contain functional antioxidant response elements (ARE), which are the DNA binding motifs for Nrf2, in their regulatory regions [14], the up-regulation of these genes during lactation indicates, at least indirectly, that the Nrf2 pathway is indeed activated in the liver of lactating sows. This is in line with recent observations in dairy cows in which the Nrf2 pathway was shown to be strongly activated in liver (unpublished observations) and spleen [15] in early lactation compared to late pregnancy. Due to the limited amount of liver tissue obtained from the biopsy sampling procedure additional assays, such as gel-shift assays providing direct evidence for activation of Nrf2 through determining of binding of Nrf2 to the ARE motif of Nrf2 target genes, could not be conducted. Due to the same reason protein levels of the Nrf2 target genes were not determined. However, several studies clearly showed that increased mRNA levels of Nrf2 target genes positively correlate with elevated levels of the encoded proteins [16, 17], suggesting that elevated Nrf2 target gene levels are suitable indicators of Nrf2 activation.
Table 2
Relative transcript levels of Nrf2 target genes in the liver of lactating and non-lactating sows on day 20 of lactation
Non-lactating (n = 10)
Lactating (n = 10)
P value
UGT1A1
1 ± 0.52
1.79 ± 0.59*
0.013
HO-1
1 ± 0.48
1.71 ± 0.42*
0.007
NQO1
1 ± 0.49
2.91 ± 1.54*
0.007
GPX1
1 ± 0.56
3.11 ± 1.19*
0.001
PRDX6
1 ± 0.56
2.12 ± 0.78*
0.008
TXNRD1
1 ± 0.28
2.99 ± 2.45*
0.029
SOD
1 ± 0.65
2.28 ± 1.01*
0.007
MT1A
1 ± 0.37
1.64 ± 1.26
0.190
Values represent mean ± SD for n = 10 sows per group. *Significantly different from non-lactating group (P < 0.05).
With regard to the mechanism underlying the activation of Nrf2 during lactation, it may be speculated that ROS, which are known activators of Nrf2 [10] and generated during an inflammatory process and an elevated energy production through the respiratory chain, are the stimuli triggering the activation of Nrf2 in the liver during lactation. Transcript levels of genes encoding acute phase proteins, such as haptoglobin (encoded by HP), fibrinogen γ (encoded by FGG), complement factor B (encoded by CFB), C-reactive protein (encoded by CRP) and lipopolysaccharide-binding protein (encoded by LBP), were clearly higher (2 to 8.7 fold) in lactating compared to non-lactating sows (P < 0.05, Table 3) providing at least indirect evidence for an inflammatory state occurring in the liver of lactating sows. In addition, the recently observed induction of energy-generating pathways (fatty acid catabolism, tricarboxylic acid cycle, respiratory chain) in livers of lactating sows [9] is supportive for an elevated energy production during lactation. The unaltered plasma levels of TBARS, which were used as markers of oxidative stress, between lactating and non-lactating sows in the present study (7.03 ± 1.54 vs. 7.02 ± 2.25 nmol/μmol triacylglycerols, n = 10/group, P > 0.05) suggests at first glance that ROS production was not elevated in sows during lactation. However, the lack of an increase in TBARS levels may be simply explained by the up-regulation of antioxidant genes which likely improved the capacity of the liver to cope with the increased levels of ROS and to prevent oxidative stress.
Table 3
Relative transcript levels of genes encoding acute phase proteins in the liver of lactating and non-lactating sows on day 20 of lactation
Non-lactating (n = 10)
Lactating (n = 10)
P value
HP
1 ± 0.89
2.58 ± 1.08*
0.005
FGG
1 ± 0.55
2.90 ± 0.66*
0.001
CFB
1 ± 0.52
2.01 ± 0.36*
0.001
CRP
1 ± 0.68
8.68 ± 4.20*
0.001
LBP
1 ± 0.71
5.82 ± 1.94*
0.001
Values represent mean ± SD for n = 10 sows per group. *Significantly different from non-lactating group (P < 0.05).
In conclusion, the results of the present study indicate that the Nrf2 pathway in the liver of sows is activated during lactation. The activation of Nrf2 pathway during lactation in sows might be interpreted as a physiologic means to counteract the inflammatory process and to protect the liver against damage induced by inflammatory signals and ROS, which are released at elevated levels as a consequence of the metabolic and immunologic adaptations occurring during the transition from pregnancy to lactation (Figure 1). Since Nrf2 is also expressed in the mammary gland, which is particularly susceptible for the induction of an inflammatory state caused by bacterial invasion via the mammary gland [18], it is likely that activation of this pathway during lactation might provide protection against bacterial derived inflammatory stimuli also in non-hepatic tissues.
Figure 1
Activation of stress signalling pathways in the liver of sows during lactation. Activation of Nrf2 and NF-κB during lactation is mediated by various stimuli including reactive oxygen species (ROS), bacterial lipopolysaccharide (LPS) and cytokines, which are known activators of both, Nrf2 and NF-κB. Activation of Nrf2 leads to up-regulation of classical Nrf2 target genes such as glutathione peroxidase 1 (encoded by GPX1), superoxide dismutase (encoded by SOD) and cytoprotective proteins [heme oxygenase 1 (encoded by HO-1), NAD(P)H dehydrogenase, quinone 1 (encoded by NQO1), peroxiredoxin 6 (encoded by PRDX6), thioredoxin reductase 1 (encoded by TXNRD1), glucuronosyltransferase 1 family, and polypeptide A1 (encoded by UGT1A1)]. Acivation of NF-κB results in the induction of acute phase proteins such as haptoglobin (encoded by HP), fibrinogen γ (encoded by FGG), complement factor B (encoded by CFB), C-reactive protein (encoded by CRP) and lipopolysaccharide-binding protein (encoded by LBP). Activation of stress signalling pathways during lactation in sows might be interpreted as a physiologic means to counteract the inflammatory process and to protect the liver against deleterious effects of inflammatory signals and ROS, which are released at elevated levels as a consequence of the metabolic and immunologic adaptations occurring during the transition from pregnancy to lactation.
Notes
Declarations
Acknowledgements
This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft; Grant no. ED 70/9-1).
Authors’ Affiliations
(1)
Institute of Animal Nutrition and Nutritional Physiology, Justus-Liebig-University
(2)
Department of Veterinary Clinical Sciences, Swine Diseases, Justus-Liebig-University
(3)
Institute for Animal Breeding and Genetics, Justus-Liebig-University
References
Trayhurn P, Douglas JB, McGuckin MM: Brown adipose tissue thermogenesis is 'suppressed' during lactation in mice. Nature. 1982, 298: 59-60. 10.1038/298059a0.View ArticlePubMedGoogle Scholar
Williamson DH: Regulation of metabolism during lactation in the rat. Reprod Nutr Dev. 1986, 26: 597-603. 10.1051/rnd:19860409.View ArticlePubMedGoogle Scholar
Loor JJ, Dann HM, Everts RE, Oliveira R, Green CA, Guretzky NA, Rodriguez-Zas SL, Lewin HA, Drackley JK: Temporal gene expression profiling of liver from periparturient dairy cows reveals complex adaptive mechanisms in hepatic function. Physiol Genomics. 2005, 23: 217-226. 10.1152/physiolgenomics.00132.2005.View ArticlePubMedGoogle Scholar
Loor JJ, Dann HM, Guretzky NA, Everts RE, Oliveira R, Green CA, Litherland NB, Rodriguez-Zas SL, Lewin HA, Drackley JK: Plane of nutrition prepartum alters hepatic gene expression and function in dairy cows as assessed by longitudinal transcript and metabolic profiling. Physiol Genomics. 2006, 27: 29-41. 10.1152/physiolgenomics.00036.2006.View ArticlePubMedGoogle Scholar
Gutgesell A, Ringseis R, Schmidt E, Brandsch C, Stangl GI, Eder K: Downregulation of peroxisome proliferator-activated receptor α and its coactivators in liver and skeletal muscle mediates the metabolic adaptations during lactation in mice. J Mol Endocrinol. 2009, 43: 241-250. 10.1677/JME-09-0064.View ArticlePubMedGoogle Scholar
Bionaz M, Loor JJ: Gene networks driving bovine mammary protein synthesis during the lactation cycle. Bioinform Biol Insights. 2011, 5: 83-98.PubMed CentralPubMedGoogle Scholar
Ringseis R, Heller K, Kluge H, Eder K: mRNA expression of genes involved in fatty acid utilization in skeletal muscle and white adipose tissues of sows during lactation. Comp Biochem Physiol A Mol Integr Physiol. 2011, 158: 450-454. 10.1016/j.cbpa.2010.12.007.View ArticlePubMedGoogle Scholar
Theil PK, Labouriau R, Sejrsen K, Thomsen B, Sørensen MT: Expression of genes involved in regulation of cell turnover during milk stasis and lactation rescue in sow mammary glands. J Anim Sci. 2005, 83: 2349-2356.PubMedGoogle Scholar
Rosenbaum S, Ringseis R, Hillen S, Lange S, Erhardt G, Reiner G, Eder K: Genome-wide transcript profiling indicates induction of energy-generating pathways and an adaptive immune response in the liver of sows during lactation. Comp Biochem Physiol D Genomics Prot. 2012, doi: http://dx.doi.org/10.1016/j.cbd.2012.09.001Google Scholar
Kim J, Cha YN, Surh YJ: A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res. 2010, 690: 12-23. 10.1016/j.mrfmmm.2009.09.007.View ArticlePubMedGoogle Scholar
Keller J, Ringseis R, Koc A, Lukas I, Kluge H, Eder K: Supplementation with L-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets. Animal. 2012, 6: 70-78. 10.1017/S1751731111001327.View ArticlePubMedGoogle Scholar
Sidwell CG, Salwin H, Benca M, Mitchell JH: The use of thiobarbituric acid as a measure of fat oxidation. J Am Oil Chem Soc. 1954, 31: 603-606. 10.1007/BF02545589.View ArticleGoogle Scholar
Jung KA, Kwak MK: The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010, 15: 7266-7291. 10.3390/molecules15107266.View ArticlePubMedGoogle Scholar
Morris DG, Waters SM, McCarthy SD, Patton J, Earley B, Fitzpatrick R, Murphy JJ, Diskin MG, Kenny DA, Brass A, Wathes DC: Pleiotropic effects of negative energy balance in the postpartum dairy cow on splenic gene expression: repercussions for innate and adaptive immunity. Physiol Genomics. 2009, 39: 28-37. 10.1152/physiolgenomics.90394.2008.PubMed CentralView ArticlePubMedGoogle Scholar
Wagner AE, Ernst I, Iori R, Desel C, Rimbach G: Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture. Exp Dermatol. 2009, 19: 137-144.View ArticlePubMedGoogle Scholar
Ernst IM, Wagner AE, Schuemann C, Storm N, Höppner W, Döring F, Stocker A, Rimbach G: Allyl-, butyl- and phenylethyl-isothiocyanate activate Nrf2 in cultured fibroblasts. Pharmacol Res. 2011, 63: 233-240. 10.1016/j.phrs.2010.11.005.View ArticlePubMedGoogle Scholar
Elmore RG, Martin CE, Berg JN: Absorption of Escherichia coli endotoxin from the mammary glands and uteri of early post-partum sows and gilts. Theriogenology. 1978, 10: 439-445. 10.1016/0093-691X(78)90133-4.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
